Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CURONASDAQ:NRBONASDAQ:PWMNASDAQ:SNTG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCUROCURO Group$0.04$0.04$0.04▼$2.25$1.69M2.21984,281 shsN/ANRBONeuroBo Pharmaceuticals$0.70+1.2%$0.78$2.08▼$5.30$6.03M-0.2652,006 shs34,797 shsPWMPrestige Wealth$0.37-0.6%$0.39$0.31▼$2.70$5.31M3.08627,916 shs56,711 shsSNTGSentage$1.75+1.5%$1.73$1.43▼$3.97$4.90M2.37149,511 shs1,700 shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCUROCURO Group0.00%0.00%0.00%0.00%-18.00%NRBONeuroBo Pharmaceuticals+1.16%-9.68%+0.14%-54.84%-81.77%PWMPrestige Wealth0.00%-7.54%-20.21%-21.96%-52.83%SNTGSentage0.00%-4.32%-1.12%-2.21%-17.03%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCUROCURO GroupN/AN/AN/AN/AN/AN/AN/AN/ANRBONeuroBo PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/APWMPrestige Wealth0.6434 of 5 stars0.05.00.00.02.20.00.0SNTGSentageN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCUROCURO Group 0.00N/AN/AN/ANRBONeuroBo Pharmaceuticals 0.00N/AN/AN/APWMPrestige Wealth 0.00N/AN/AN/ASNTGSentage 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCUROCURO Group$418.33M0.00$2.05 per share0.02($1.34) per share-0.03NRBONeuroBo PharmaceuticalsN/AN/AN/AN/A$1.50 per shareN/APWMPrestige Wealth$639.91K8.30N/AN/A$0.21 per share1.75SNTGSentage$107.51K45.53N/AN/A$3.65 per share0.48Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCUROCURO Group-$266.73M-$6.49N/AN/AN/A-35.34%N/A-8.23%N/ANRBONeuroBo Pharmaceuticals-$12.47MN/A0.00N/AN/AN/A-189.12%-122.31%8/12/2025 (Estimated)PWMPrestige Wealth-$6.88MN/A0.00∞N/AN/AN/AN/AN/ASNTGSentage-$2.01MN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCUROCURO Group$0.441,073.17%N/AN/A N/ANRBONeuroBo PharmaceuticalsN/AN/AN/AN/AN/APWMPrestige WealthN/AN/AN/AN/AN/ASNTGSentageN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCUROCURO GroupN/A9.339.33NRBONeuroBo PharmaceuticalsN/A2.412.41PWMPrestige WealthN/A1.121.12SNTGSentage0.017.437.43Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCUROCURO Group39.87%NRBONeuroBo Pharmaceuticals1.37%PWMPrestige Wealth7.68%SNTGSentage0.05%Insider OwnershipCompanyInsider OwnershipCUROCURO Group26.12%NRBONeuroBo Pharmaceuticals1.05%PWMPrestige WealthN/ASNTGSentage62.36%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCUROCURO Group5,20041.30 million30.51 millionOptionableNRBONeuroBo Pharmaceuticals108.62 million8.53 millionNot OptionablePWMPrestige Wealth414.47 millionN/ANot OptionableSNTGSentage202.81 million1.06 millionNot OptionableCURO, NRBO, PWM, and SNTG HeadlinesRecent News About These CompaniesSentage Holdings Delays Yearly Report FilingApril 30, 2025 | tipranks.comWhy Did Sentage Holdings Inc (SNTG) Stock See -14.08% Plunge in the Last 90 Days?December 26, 2024 | bovnews.comSentage Holdings Inc. Announces Financial Results for the First Six Months of Fiscal Year 2024December 17, 2024 | prnewswire.comSentage Hldgs (NASDAQ:SNTG) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.comSentage Holdings Inc (SNTG) Surges 6.55% Amidst Market FluctuationsOctober 2, 2024 | gurufocus.comTrupanion, CNFinance among financial moversMay 15, 2024 | msn.comSentage Holdings Full Year 2023 Earnings: US$0.80 loss per share (vs US$1.08 loss in FY 2022)April 28, 2024 | finance.yahoo.comCleanspark, Digital World Acquisition among financial moversMarch 20, 2024 | msn.comMarch 7, 2024 | en.ethereumworldnews.comSentage Holdings Inc. Cl AFebruary 24, 2024 | wsj.comWhy Is Sentage (SNTG) Stock Up 86% Today?January 9, 2024 | investorplace.comWall Street Set to Open 2024 Lower Amid Rise in Oil Prices, Ahead of Manufacturing, Construction DataJanuary 2, 2024 | msn.comU.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.05%December 29, 2023 | msn.comWhy Sentage Holdings Shares Are Trading Lower By 5%; Here Are 20 Stocks Moving PremarketDecember 26, 2023 | msn.comTesla, Apple And 3 Stocks To Watch Heading Into TuesdayDecember 26, 2023 | msn.comSentage Hldgs Stock (NASDAQ:SNTG), Guidance and ForecastDecember 23, 2023 | benzinga.comSentage Hldgs Stock (NASDAQ:SNTG) Dividends: History, Yield and DatesDecember 23, 2023 | benzinga.comSentage Holdings GAAP EPS of -$0.46, revenue of $0.08MDecember 22, 2023 | msn.comSentage Holdings Inc. Announces Financial Results for the First Six Months of Fiscal Year 2023December 22, 2023 | finance.yahoo.comSentage Holdings Inc - Ordinary Shares - Class ADecember 19, 2023 | money.usnews.comMedia Sentiment Over TimeCURO, NRBO, PWM, and SNTG Company DescriptionsCURO Group NYSE:CUROCURO Group Holdings Corp., together with its subsidiaries, provides consumer finance products in the United States and Canada. The company offers secured and unsecured installment loans, revolving line of credit, and single-pay loans; and credit protection insurance, check cashing, money transfer, foreign currency exchange, and other ancillary financial products and services, as well as reloadable prepaid debit cards and demand deposit accounts. The company also provides loans through online. It operates under the Covington Credit, Heights Finance, Quick Credit, Southern Finance, First Heritage Credit, Cash Money, LendDirect, and Flexiti brands. The company was formerly known as Speedy Group Holdings Corp. and changed its name to CURO Group Holdings Corp. in May 2016. CURO Group Holdings Corp. was founded in 1997 and is headquartered in Chicago, Illinois.NeuroBo Pharmaceuticals NASDAQ:NRBO$0.70 +0.01 (+1.16%) As of 06/18/2025NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for metabolic dysfunction-associated steatohepatitis (MASH), and has completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus (T2DM); and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in preclinical development for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene. NeuroBo Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.Prestige Wealth NASDAQ:PWM$0.37 0.00 (-0.57%) Closing price 03:17 PM EasternExtended Trading$0.36 0.00 (-0.82%) As of 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prestige Wealth Inc., through its subsidiaries, provides wealth management and asset management services. It assists its clients in identifying and purchasing wealth and asset management products. The company offers its services primarily for high net worth and ultra-high net worth individuals, including business owners, executives, heirs of rich families, and other affluent individuals in Asia primarily in the mainland China or Hong Kong. The company was incorporated in 2018 and is based in Central, Hong Kong. Prestige Wealth Inc. is a subsidiary of Prestige Financial Holdings Group Limited.Sentage NASDAQ:SNTG$1.74 +0.03 (+1.45%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Sentage Holdings Inc. provides a range of financial services. The company offers consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China. It also provides consultancy and information technology support services. Sentage Holdings Inc. was incorporated in 2019 and is headquartered in Shanghai, the People's Republic of China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
